drug class of tirzepatide π§ Let's break the down using this mnemonic cloud!β β π Tirzepatide is a GLP-1 and GIP agonist. β β π€But what exactly is glucagon-like peptide (GLP-1) and gastric inhibitory polypeptide (GIP)? β β Mounjaro (tirzepatide): Uses, Side Effects,
Description
1 - 2 - 2 - 1 0,25
How much to increase by Standard increases follow the dose doubling pattern used in clinical trials
GLP-1 medications are impacting more than just users physical health
Most adverse events were mild to moderate and resolved within the first month of treatment, with symptom improvement continuing throughout the trial period
Most patients notice appetite reduction within 12 weeks, but measurable weight loss typically appears after 48 weeks of consistent dosing
